Recurrent spontaneous coronary dissections in a patient with a de novo fibrillin-1 mutation without Marfan syndrome

Philipp von Hundelshausen; Konrad Oexle; Kiril Bidzhekov; Martin M Schmitt; Michael Hristov; Xavier Blanchet; Harald Kaemmerer; Gabor Matyas; Thomas Meitinger; Christian Weber

doi:10.1160/TH14-11-0913

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2015; 113(03): 668-670
DOI: 10.1160/TH14-11-0913

Letters to the Editor

Schattauer GmbH

Recurrent spontaneous coronary dissections in a patient with a de novo fibrillin-1 mutation without Marfan syndrome

Authors

Philipp von Hundelshausen

¹Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany

²German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
Konrad Oexle

³Institute of Human Genetics, Technical University Munich, Munich, Germany

⁴Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany
Kiril Bidzhekov

¹Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany

²German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
Martin M Schmitt

¹Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany

²German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
Michael Hristov

¹Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany

²German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
Xavier Blanchet

¹Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany

²German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
Harald Kaemmerer

⁵Department of Pediatric Cardiology and Congenital Heart Defects, German Heart Centre Munich, Technical University Munich, Munich, Germany
Gabor Matyas

⁶Center for Cardiovascular Genetics and Gene Diagnostics, Foundation for People with Rare Diseases, Zurich, Switzerland
Thomas Meitinger

²German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany

³Institute of Human Genetics, Technical University Munich, Munich, Germany

⁴Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany
Christian Weber

¹Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany

²German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany

Abstract

Full Text

References

References
1 Tweet MS, Hayes SN, Pitta SR. et al. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation 2012; 126: 579-588.
2 Loeys BL, Dietz HC, Braverman AC. et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476-485.
3 Grond-Ginsbach C, Pjontek R, Aksay SS, Hyhlik-Durr A, Bockler D, Gross-Weissmann ML. Spontaneous arterial dissection: phenotype and molecular pathogenesis. Cell Mol Life Sci 2010; 67: 1799-1815.
4 Daniel JM, Sedding DG. Circulating smooth muscle progenitor cells in arterial remodeling. J Mol Cell Cardiol 2011; 50: 273-279.
5 Rybczynski M, Bernhardt AMJ, Rehder U. et al. The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome. Am J Med Genet Part A 2008; 146A: 3157-3166.
6 Exome Aggregation Consortium (ExAC), Cambridge, MA, USA. Available at: http://exac.broa-dinstitute.org . Accessed November 14, 2014.